- Metabolite
- HMDB0000053 (Androstenedione)
- Biospecimen
- Blood
- Status
- Detected and Quantified
- Data source
- Referenced
- Concentration
- 0.0090 +/- 0.0046 uM
- Age
- Adult (>18 years old)
- Sex
- Female
- Condition
- Polycystic ovary syndrome (PCOS)
Comments
Measured in plasma before pioglitazone treatment
References
- Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R: Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. Clin Pharmacol Ther. 2006 Aug;80(2):105-14. Epub 2006 Jun 30. [PubMed:16890572 ]